pain, vaginal problems, weight problems and nausea at 1 year after completion of conventional treatment (Ganz, Kwan, Stanton, Bower, & Belin, 2011) . In addition, fatigue, menopausal symptoms, neuropathy and insomnia were also commonly reported in breast cancer survivors (Huang et al., 2015) . Fatigue and depression were common in disease-free breast cancer survivors and interfered with their quality of life (Kim et al., 2008) . Colorectal cancer survivors reported lack of energy, sexual functioning, bowel problems, poor body image and emotion problems 5 years after treatment (Phipps, Braitman, Stites, & Leighton, 2008) . A systematic review indicated that the most common long-term symptoms among breast and colorectal cancer survivors who had completed conventional treatment were prolonged fatigue, cognitive limitations, depression and anxiety, sleep problems, pain and sexual function (Harrington et al., 2010) .
These symptoms interfere with emotional and physical function, and quality of life among cancer survivors (Knobf, 2011) .
According to the MD Anderson Symptom Inventory (MDASI), symptom severity is the severity of symptoms experienced by patients with cancer, while symptom interference is the interference with daily living caused by these symptoms (MD Anderson Cancer Center, 2018) . The MDASI measured 13 core symptom items that have the highest frequency and/or severity as well as six aspects of daily living where interference caused by symptoms was most common in patients with various cancer and treatment types (MD Anderson Cancer Center, 2018) . The 19 core MDASI symptom and interference items were generic to all patients with cancer. Common long-term symptoms among breast and colorectal cancer survivors, such as fatigue, cognitive limitations, sadness, distress and pain, were included in the MDASI core symptoms. Additional items that are unique to a particular patient population could be added to form the disease site-specific and treatment-specific MDASI modules (MD Anderson Cancer Center, 2018) . The MDASI was used in the current study because that the MDASI has been extensively validated and used in research of cancer patients (Reilly et al., 2013) and the inclusion of comprehensive core symptoms. We added interference of sexual function to the interference items because breast and colorectal cancer survivors reported such concern and it was not included in the MDASI modules (Ganz et al., 2011; Harrington et al., 2010) .
Taiwan is a modern Chinese society with a 2-tiered medical system, conventional medicine and traditional medicine. The costs of both are generally covered by National Health Insurance. In addition to the two formal medical systems, traditional healers compose an informal system of care. A study among Taiwanese cancer patients found that 49.7% of cancer survivors used traditional Chinese medicine (TCM) to supplement Western medicine during conventional treatment (Chen, Tseng, Tsang, & Hong, 2008) . A systematic review indicated that the most often used type of CAM among breast cancer survivors was biology-based medicine (including herbs, vitamins, and foods), followed by mind-body medicine (including meditation, prayer and mental healing) (Wanchai, Armer, & Stewart, 2010) . The American National Health Interview Survey in 2002 found that cancer survivors used CAM to relieve insomnia, excessive sleepiness, anxiety and depression (Anderson & Taylor, 2012) .
Cancer survivors used CAM in hopes of decreasing symptom severity and side effects resulting from conventional treatment, recovering and promoting health, boosting the immune system and preventing cancer relapse (Corner et al., 2009; Huang et al., 2015; Mao, Farrar, Xie, Bowman, & Armstrong, 2007; Molassiotis et al., 2006; Rakovitch et al., 2005 (Corner et al., 2009; Huang et al., 2015; Mao et al., 2007; Molassiotis et al., 2006; Rakovitch et al., 2005) . But few studies have focused on cancer survivors after completion of conventional treatment. To the best of our knowledge, there is no study on this issue in non-Western countries or Taiwan.
As CAM become more popular and more cancer patients survive through conventional treatment around the world, CAM use among long-term cancer survivors will become more common. So the objectives of this study were to compare symptom severity, symptom interference with daily life, and use of CAM between colorectal or breast cancer survivors after curative treatment and individuals who did not have cancer in Taiwan, and to examine factors associated with CAM use among cancer survivors. The study results could help health care workers to understand needs of cancer survivors in order to provide quality care, probably incorporating CAM suggestions, for them.
| PATIENT AND ME THODS

| Study samples
This study used a cross-sectional survey design. Two groups of participants, cancer survivors after curative treatment (survivor group) and healthy individuals without cancer (comparison group), were recruited at a regional and teaching hospital in northern Taiwan. The survivor group was from the cancer registration database at the study hospital. Since majority of cancer survivors in the hospital database were colorectal and breast cancers, we decided to focus on the two cancers.
The inclusion criteria were adult cancer survivors who had been diag- 
| Ethical consideration
Each participant signed an informed consent form before the data were collected. The study ethics were reviewed and approved by an Institutional Review board and approval was obtained from the study hospital (CGH-P102006).
| Sample size considerations
There was a lack of previous study comparing CAM use between cancer survivors and comparisons in Taiwan. We assumed a medium effect size of 0.4 (Polit & Beck, 2017) ; when the two-sided α was 0.05 and power was 0.8, the required sample size was 98 per group. Therefore, we decided to include at least 100 individuals per group.
We examined the cancer registration system at the study hospital and found that there were about 60-80 eligible patients in 1 year.
To meet the required sample size, we decided to recruit all registered patients in the most recent 2 years and used a 1 to 1 ratio to recruit the comparison group.
| Measurements
Participants were interviewed face-to-face by the researcher (the first author) using structured questionnaires from May to September, 2013. The study variables included participant demographics (sex, age, marital status, educational level, work status and household in- 
| Statistical analysis
The data analysis was performed using SPSS version 18.0. Descriptive statistics were used to describe patient and disease characteristics.
Since the data were collected through face-to-face interview by the researcher, there was no missing data. Bivariate analysis was conducted using the independent t test, Pearson chi-squared tests, or
Fisher's exact tests. Multivariate logistic regression was used to examine factors associated with CAM use among cancer survivors.
Factors that were associated with CAM use with a two-sided p-value of less than 0.25 in bivariate analyses were entered into the multiple logistic regression models. Then, we dropped one least significant variable at a time until all independent variables in the multiple logistic regression model had a two-sided p-value of less than 0.05.
| RE SULTS
Participant characteristics are presented in 
| D ISCUSS I ON
The study found that cancer survivors who had completed curative treatment for 1-5 years were more likely to be current CAM 
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Comparison of symptom severity and symptom interference with daily life between users and non-users of complementary and alternative medicine in the survivor group users than their healthy counterparts. The survivor group had a significantly higher rate of use of TCM and herbs. Although the survivor group also reported higher rates of use of natural products and mind and body practices than the comparison group, the differences were not statistically significant. A study using the 2002 US National Health Interview Survey found that cancer survivors used more CAM than the general population. The most commonly used types of CAM were herbs, deep breathing and meditation (Fouladbakhsh & Stommel, 2008) . A Japanese national survey revealed that cancer survivors had higher rates of CAM use than non-cancer patients. The most commonly used types of CAM were Agaricus (a mushroom extract), propolis and
Chinese herbs (Hyodoet al., 2005) . The study population was different in these three studies; our study focused on breast and colorectal cancer survivors who were currently cancerfree 1-5 years after completion of conventional treatment. The US study was a population-based survey focusing on individuals who had been given a diagnosis of cancer for more than one year, and the Japanese study targeted cancer patients receiving palliative or hospice care. Nonetheless, all studies consistently showed that cancer survivors had higher rates of current CAM use than individuals without cancer. The most frequently used type of CAM was natural products, although participants were at different disease stages.
The cancer survivors in this study were more likely to use TCM than those reported in previous studies (Hyodoet al., 2005; Maoet al., 2007; Yang, Chien, & Tai, 2008) . Chinese people often use TCM to treat symptoms. In addition, TCM is covered by National Health
Insurance and is part of the medical system in Taiwan. Cancer survivors may still feel their health is suboptimal after conventional treatment and feel they need medical treatment (Grov, Fosså, & Dahl, 2011; Mao et al., 2008; Wanchai et al., 2010) . Cultural background and disease stage may influence the type of CAM used among cancer survivors (Fouladbakhsh & Stommel, 2008; Gansler, Kaw, Crammer, & Smith, 2008; Hyodo et al., 2005; Molassiotis et al., 2005; Trinkaus et al., 2011) .
In the study, the participants in the survivor and comparison groups both reported low mean levels of symptom severity and interference (0.25-2.94 on a 0-10 scale). Nonetheless, we found that the survivor group did not have higher symptom severity and symptom interference than their healthy counterparts, contrary to findings in previous studies (Fouladbakhsh & Stommel, 2008; Grov et al., 2011; Hyodo et al., 2005) . Previous studies did not apply inclusion criteria of cancer-free after conventional anti-cancer treatment, which could be the reason for their findings of higher symptom severity and interference among cancer survivors than healthy comparisons. The National Health Interview Survey in Taiwan (Hsiung & Wang, 2016) . The finding suggested that general population in Taiwan also revealed some level of symptom severity and interference. Cancer survivors had experienced much higher symptom severity and interference during anti-cancer treatment (Huang et al., 2013) . Researchers have reported experiencing growth through adversity among cancer survivors (Sherman, Rosedale, & Haber, 2012) .
Therefore, long-term cancer survivors may be more tolerant for symptoms. Alternatively, our results may suggest that colorectal and breast cancer survivors 1-5 years after conventional treatment had regained their health so that their symptom severity and interference
were not different than the comparisons. Since previous studies of long-term cancer survivors did not apply criteria of cancer-free after conventional anti-cancer treatment and rarely applied a comparison group, those hypotheses need to be examined in future studies.
Though there were no significant differences in mean total scores for symptom severity and symptom interference between the two groups, the comparison group reported significantly higher levels of pain, nausea, shortness of breath, lack of appetite, sadness and vomiting than the cancer survivors. The finding that the general population is not that healthy was supported by the national surveys in Taiwan and the US (Hsiung & Wang, 2016 Table 1 ). Future study could collect more detailed information of diseases and symptoms in order to explain the higher severity of those symptoms in the presumably healthy comparisons than the cancer survivors.
The only symptom that had significant higher level of severity for the survivor group than the control group was sleep disturbance. Nonetheless, cancer survivors who used CAM reported higher levels of symptom interference, especially in sexual life, enjoyment of life and mood. The finding that cancer survivors usually used CAM to deal with symptom interference was consistent with previous studies (Fouladbakhsh & Stommel, 2008) . We found that sexual life was an important aspect of the symptom interference among long-term colorectal and breast cancer survivors that were not covered by the MDASI. Previous studies also reported that sexual life interference was concerns among colorectal and breast cancer survivors (Ganz et al., 2011; Harringtonet al., 2010 among cancer survivors. This is compatible with a previous study which showed that more than 59% of cancer survivors used CAM (Corner et al., 2009) . Our study confirms previous results that cancer survivors who had used CAM during curative treatment were more likely to use CAM even after completion of curative treatment (Corner et al., 2009) . Contrary to previous studies (Corner et al., 2009; Fouladbakhsh, Stommel, Given, & Given, 2005; Mao et al., 2008; Molassiotis et al., 2005; Wanchai et al., 2010) , age, education and income were not significantly related to CAM use among survivors. This may be due to that many CAM users in the survivor group had already used CAM when they received the anti-cancer treatment and they continued their CAM use as long-term survivors; therefore, the significance of those variables was explained by prior experience of CAM use.
CAM nursing intervention could improve quality of life among cancer survivors (Klafke et al., 2016 
| Limitations
The study applied a cross-sectional design, and thus, the reported association is correlational rather than causal. For example, higher symptom interference being positively associated with CAM use among cancer survivors could not be used to examine the effectiveness of CAM, which is beyond the objective of the current study. Further study is needed to examine the effectiveness of CAM in alleviating symptom interference among cancer survivors. The study samples were recruited at one hospital; thus, generalisability is limited. The cancer survivors in the study were limited to survivors of colorectal cancer and breast cancer stage I to III 1 to 5 years after completion of conventional treatment.
The comparison group reported significantly greater pain, nausea, shortness of breath, lack of appetite, sadness and vomiting than the survivor group, though the overall symptom severity was not significantly different. The large standard deviations of symptom severity among the comparison group suggest that there may be large variations in responses. Since the comparison group was recruited from hospital volunteers, families of patients who visited outpatient clinics, and participants in community cancer screening programs, there may be more family caregivers and more with chronic illness/symptoms than in the general population.
Unfortunately, the related information was not collected in the study. Population-based study of cancer survivors and comparison group is needed. 
| CON CLUS ION
